Abstract 3707: The multitargeted kinase inhibitor dasatinib induces DNA damage, Hippo pathway engagement and senescence in lung cancer cell lines that possess kinase-inactivating BRAF mutations

MLA

Faye M. Johnson, et al. “Abstract 3707: The Multitargeted Kinase Inhibitor Dasatinib Induces DNA Damage, Hippo Pathway Engagement and Senescence in Lung Cancer Cell Lines That Possess Kinase-Inactivating BRAF Mutations.” Cancer Research, vol. 74, Oct. 2014, p. 3707. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........cfb1ebd10bf31e7a488301d17fce28d3&authtype=sso&custid=ns315887.

APA

Faye M. Johnson, Banibrata Sen, Tuhina Mazumdar, Lauren Averett Byers, Humam Kadara, & Shaohua Peng. (2014). Abstract 3707: The multitargeted kinase inhibitor dasatinib induces DNA damage, Hippo pathway engagement and senescence in lung cancer cell lines that possess kinase-inactivating BRAF mutations. Cancer Research, 74, 3707.

Chicago

Faye M. Johnson, Banibrata Sen, Tuhina Mazumdar, Lauren Averett Byers, Humam Kadara, and Shaohua Peng. 2014. “Abstract 3707: The Multitargeted Kinase Inhibitor Dasatinib Induces DNA Damage, Hippo Pathway Engagement and Senescence in Lung Cancer Cell Lines That Possess Kinase-Inactivating BRAF Mutations.” Cancer Research 74 (October): 3707. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........cfb1ebd10bf31e7a488301d17fce28d3&authtype=sso&custid=ns315887.